$UTI

DEVINCENZI ROBERT THOMAS purchased $226K of UTI

DEVINCENZI ROBERT THOMAS purchased 8,000 shares of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) at $28.21 ($0.23M total) on 2026-08-10.

Original reporting
SEC EDGAR · DEVINCENZI ROBERT THOMAS
Published Aug 13, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$UTI
Bullish
medium confidence
Mentioned
$UTI
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UTIBullishLow
01

Why it matters

The newest fact is the director’s open-market purchase of 8,000 shares at a stated price, which may slightly influence sentiment but does not change fundamentals in the text.

02

Market read

Traders may note insider buying as a small sentiment input, but there is no accompanying earnings, guidance, deal, or regulatory development.

03

What to watch

The article does not state motivation, prior trading history, or whether the director’s holdings are already large, limiting inference from the single transaction.

Relevance 5/10Novelty 5/10Timing: filed 2026-08-12 after purchase dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for Universal Technical Institute Inc (UTI).

Company-level read

Ticker impact

$UTIBullishMedium confidence
Context

SEC Form 4 shows director Robert Thomas Devincenzi bought 8,000 shares of UTI at $28.2095 on 2026-08-10.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades without follow-on fundamentals.

Evidence & confidence

The filing is a primary-source insider transaction, but the article provides no new company-specific operational or financial catalyst beyond the purchase.

Market effects

No sector-level implications disclosed.

None disclosed.

None disclosed.

Counterpoint

Insider buys can be routine, tax-related, or part of pre-planned behavior even when not under a 10b5-1 plan.

Key entities

  • UNIVERSAL TECHNICAL INSTITUTE INC

    Company whose director insider transaction is disclosed on SEC Form 4.

  • DEVINCENZI ROBERT THOMAS

    Director who purchased 8,000 shares on 2026-08-10.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UTIMed

UTI Expands Credit Facility to $200 Million in New Five

Universal Technical Institute (UTI) secured a new $200M revolving credit facility, up from $125M, with a five-year term. The facility, led by Fifth Third Bank, includes a $75M letter of credit sublimit and a $75M incremental facility option. UTI plans to use the funds for working capital, internal initiatives, and potential acquisitions. The expanded lending syndicate suggests increased institutional confidence in UTI's growth strategy.

$UTIMed

Universal Technical Institute Secures $200 Million Revolving Credit Facility, Maturing 2031

Universal Technical Institute (UTI) secured a $200 million revolving credit facility maturing in 2031, refinancing its prior agreement and bolstering liquidity. The facility, arranged by Fifth Third Bank, includes a $15 million swingline, a $75 million letter-of-credit sublimit, and up to $75 million of uncommitted incremental capacity. Borrowings bear interest at Term SOFR plus 1.50%–2.25% or Base Rate plus 0.50%–1.25%, with an unused fee of 0.20%–0.35%. The company also executed a Guaranty and

$UTIMedAI 8/10

Universal Technical Institute Q3 Earnings Call Highlights

Universal Technical Institute (NYSE:UTI) reported Q3 revenue of $138 million, up 5%, and Concorde revenue of $80.9 million, up 11.1%. Management cited employer shortages and said high school automotive and diesel starts were below expectations due to admissions execution. FY2026 guidance: revenue $893m-$900m, net income $32m-$36m, EPS $0.57-$0.64, baseline adj. EBITDA >$135m.

$UTIMed

UNIVERSAL TECHNICAL INSTITUTE INC (UTI): Results of Operations and Financial Condition

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Universal Technical Institute Reports Fiscal Year 2026 Third Quarter Results Total New Student Start Growth Exceeded Expectations Driven by Strong Demand and Continued Momentum Across New Campuses, Reinforcing Confidence in Long-Term North Star Targets PHOENIX, ARIZ.

$UTIMedAI 8/10

UTI Asset Management Company Limited Reports Q1 FY27 Results; Consolidated Total Income Up 6.7% YoY to ₹585 Crore; Total Group AUM Crosses ₹20.56 Lakh Crore

UTI Asset Management Company Limited (UTI AMC) reported unaudited Q1 FY27 results for the quarter ended June 30, 2026. Consolidated total income rose 6.7% YoY to ₹585.23 crore, with consolidated PAT attributable to owners up 24.1% YoY to ₹293.86 crore. Group AUM crossed ₹20.56 lakh crore and live folios reached 1.42 crore, with SIP inflows of ₹2,502 crore. Source: Equity Bulls.